Company / Return on Assets (ROA)
Entrada Therapeutics, Inc. Return on Assets (ROA) History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
17.4%
FY2025
5-year range
-20.2% / 17.4%
FY2023-FY2025
Trend
+1469.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) changed +1469% YoY in FY2025, a notable deviation from the 2-year average annual change of +781%.
Based on SEC 10-K filings.
17.4% in FY2025.
Improved from -20.2% to 17.4% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 1469.3% year-over-year.
Company context
Key Data Points
- Altman Z-Score -2.03 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 17.4% | +1469.3% |
| FY2024 | -1.3% | +93.7% |
| FY2023 | -20.2% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026